Neutralization of TNF by a monoclonal antibody improves survival and reduces organ dysfunction in human sepsis: Results of the MONARCS trial. - Panacek,E.A.; Marshall,J.; Fischkoff,S.; Barchuk,W.; Teoh,L. (Chest, 2000)